Trial intelligence / Profile preview

FRM vs Botulinum Toxin A for Primary Axillary Hyperhidrosis

NCT03054480Completed

Sponsor
Mae Fah Luang University Hospital
Start
Aug 2016
Primary completion
Dec 2016
01

Overview

Randomised, open-label trial (2 arms), sponsored by Mae Fah Luang University Hospital. Primary endpoint: Hyperhidrosis Disease Severity Score at 12 weeks. Started Aug 2016; status: completed.

Beyond the preview

Go deeper on NCT03054480.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03054480.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call